Nanoparticle-Based Composition for Cancer Management
Tech ID
P06-1175
Patent Status
Granted in India
Design Status
--
Technical Description
This invention pertains to a nanoparticle-based composition designed for cancer treatment by inhibiting cell proliferation, angiogenesis, tumor growth, and anti-proliferative activity.
Problems Addressed
- Inefficient Drug Delivery
- Improper Cancer Management
- Nonspecific Targeted Delivery
- Expensive
- Systemic Cytotoxicity
- Poor Biocompatibility
TARGET AUDIENCE
- Pharmaceutical Industry
- Oncology Clinics& Treatment Centres
- Nano Medicine & Drug Delivery Industry
- Research & Development
TECH FEATURES
- Lung Cancer Management
- Inhibits Cell Proliferation
- Sustained Drug release
- Specific Targeted Delivery
- No Cytotoxicity
- Prevents Burst Release of Composition
- Effective Absorption Capacity
- Cost-friendly
P06-1175
Send download link to email.
Available For
Available for exclusive and non exclusive license
Sell off
Cost
—
Stage of Developments
Technology Validated
Contact Person
Mr. Lalit Ambastha
IP Bazzaar Technology Pvt. Ltd.
IP Bazzaar Technology Pvt. Ltd.
12 First Floor, National Park, Lajpat Nagar-IV,
New Delhi-110024, India
Tel: [+91] 11-26360036;
Fax: [+91] 11-26360037;
Mobile: [+91]9811367838;
Email: tech@ipbazzaar.com;
www.ipbazzaar.com
New Delhi-110024, India
Tel: [+91] 11-26360036;
Fax: [+91] 11-26360037;
Mobile: [+91]9811367838;
Email: tech@ipbazzaar.com;
www.ipbazzaar.com